2-year outcomes from the EXPAND G4 study presented at PCR LV 2025 by F. De Marco
The data confirm the durable safety and effectiveness of the MitraClip system in more than 1100 patients treated in the real-world setting.
LEARN MORE:
Related Resources
New clinical evidence and patient selection M-TEER therapy
Artifical intelligence in structural heart imaging
Anatomy for structural heart therapies
Why Amulet™ LAAO: An Experts Opinion
The Standard of Caring For TR
EACTS Symposium 2025
TriClip Symposium | PCR LV 2025
bRIGHT interview with X. Freixa | PCR LV 2025